Revascularization in heart failure: the role of percutaneous coronary intervention

Ajay J Kirtane1, Jeffrey W Moses

  • 1Columbia University Medical Center, New York, NY 10032, USA.

Heart Failure Clinics
|July 24, 2007
PubMed

Insights

Revascularization for ischemic heart failure offers benefits despite risks. Advances in percutaneous coronary intervention (PCI) may improve outcomes for high-risk patients with reduced ejection fraction.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Heart Failure Research

Background:

  • Revascularization in ischemic heart failure is complex but beneficial.
  • Coronary artery bypass grafting (CABG) historically showed superiority over percutaneous coronary intervention (PCI) in patients with reduced ejection fraction.
  • Previous studies predated modern PCI advancements like drug-eluting stents and novel support devices.

Purpose of the Study:

  • To evaluate the evolving role of PCI in patients with heart failure of ischemic origin.
  • To assess the impact of contemporary PCI techniques on clinical outcomes in this high-risk group.
  • To explore how new cardiac support devices might mitigate risks associated with PCI in patients with depressed ejection fraction.

Main Methods:

  • Review of existing literature comparing CABG and PCI in ischemic heart failure.
  • Analysis of outcomes data considering the era of balloon angioplasty versus modern drug-eluting stent technology.
  • Consideration of the potential impact of novel cardiac support devices, including intra-aortic balloon pumps.

Main Results:

  • While CABG showed benefits, older studies may not reflect current PCI efficacy.
  • Drug-eluting stents have significantly reduced repeat revascularization rates after PCI.
  • Emerging cardiac support technologies may lower periprocedural complications for high-risk PCI candidates.

Conclusions:

  • Revascularization remains crucial for managing ischemic heart failure.
  • Contemporary PCI, enhanced by drug-eluting stents and support devices, presents a potentially safer and effective alternative for select high-risk patients.
  • Further research is warranted to define the optimal revascularization strategy in the current therapeutic landscape.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...